LSD is back with a flurry of new applications to treat a broad array of conditions. The post LSD Finds New Life in Mental Health Circles...
Universal Ibogaine Inc. (TSXV:IBO), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, is pleased to announce...
The Women in Psychedelics Network , a network of professionals from all corners of the psychedelic industry strengthening women’s voices and providing...
Robert Huizinga → According to an SEC filing, Aurinia’s EVP of research Robert Huizinga and CMO Neil Solomons are both walking away by Halloween, and...
The founder of two leading psychedelic science companies and an influential nonprofit is shaping research, as well as efforts to patent it. The post...
The article News You Might Have Missed: Oct 27th, 2022 was originally published on Microdose. Welcome to the News You Might Have Missed, a weekly roundup...
Eleusis’ IV form of psilocin will see clinical trials, but Eleusis-backed research into the anti-inflammatory properties of psychedelics is uncertain....
Awakn Life Sciences Corp. (NEO: AWKN | OTCQB: AWKNF | FSE: 954), a revenue-generating biotechnology company researching, developing, and commercializing...
More groups are researching the effect of psychedelics on TBI. The post Doctors Look to Psychedelics to Address Concussion Crisis appeared first on Green...
Psychedelic medicines company Beckley Psytech has reached an agreement to acquire its rival Eleusis Therapeutics, in alignment with The post Consolidation...